Physician profile
Gregory Marra
NPI 1275997140
$11,792.34
in general payments reported to CMS, 2019-2025
54 companies · $3,147 in 2025
The $3,147 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $399 · 2021: $797 · 2022: $1,923 · 2023: $2,684 · 2024: $2,732 · 2025: $3,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,563.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,481.94 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $1,171.12 | 2019-2025 | |
| Lilly USA, LLC | $1,165.73 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,126.67 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $896.22 | 2022-2025 | |
| Glaxosmithkline, LLC. | $830.35 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $575.54 | 2022-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Amgen INC. | $521.45 | 2020-2025 | Repatha, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $392.18 | 2020-2024 | Xarelto |
| Exact Sciences Corporation | $370.95 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $340.51 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $216.56 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Dexcom, INC. | $171.75 | 2022-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $170.95 | 2024-2025 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $169.13 | 2025 | Caplyta |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $135.34 | 2023-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $122.97 | 2022-2023 | |
| Corcept Therapeutics | $120.58 | 2024-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.11 | 2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $108.38 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $106.28 | 2022-2024 | Rexulti |
| Sumitomo Pharma America, INC. | $102.36 | 2023-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $101.29 | 2022 | |
| Idorsia Pharmaceuticals US INC | $99.19 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $94.01 | 2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $87.50 | 2022-2024 | Eliquis, Camzyos |
| Recor Medical INC | $85.27 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abbott Laboratories | $70.45 | 2024-2025 | Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $68.07 | 2024-2025 | Sapien 3 Ultra Resilia |
| Pentax of America, INC. | $66.03 | 2023-2025 | Inspira, Pentax Medical, C2 Cryoballoon Focal Controller |
| Kowa Pharmaceuticals America, INC. | $62.50 | 2022 | |
| Insulet Corporation | $61.92 | 2025 | Omnipod |
| Rayner Intraocular Lenses Limited | $58.42 | 2025 | Omidria |
| Shield Therapeutics INC | $53.88 | 2023 | Accrufer |
| Amneal Pharmaceuticals LLC | $48.40 | 2024 | Unithroid |
| Takeda Pharmaceuticals U.S.A., INC. | $45.68 | 2022-2025 | Trintellix |
| Eisai INC. | $37.58 | 2021 | |
| Ferring Pharmaceuticals INC. | $35.52 | 2025 | Rebyota |
| Fujifilm Healthcare Americas Corporation | $33.75 | 2023 | Fujifilm |
| Oyster Point Pharma, INC. | $22.53 | 2024 | Tyrvaya |
| Boston Scientific Corporation | $22.17 | 2025 | Watchman Flx |
| Ardelyx, INC. | $19.78 | 2024 | Ibsrela |
| Amarin Pharma, INC. | $19.62 | 2022 | |
| Rxsight INC | $19.26 | 2023 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Optinose US, INC. | $19.07 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $18.03 | 2023 | Prehevbrio |
| Genentech USA, INC. | $17.83 | 2019 | |
| Lundbeck LLC | $17.52 | 2022 | |
| Bausch & Lomb Americas INC. | $17.50 | 2024 | Vyzulta |
| Hikma Pharmaceuticals USA | $16.82 | 2023 | Ryaltris |
| Daiichi Sankyo INC. | $15.65 | 2023 | Injectafer |
| Ibsa Pharma INC. | $14.30 | 2024 | Licart, Tirosint |
| Biohaven Pharmaceuticals, INC. | $13.68 | 2021 | |
| Travere Therapeutics, INC. | $13.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Marra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.